Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | BTN3A3 |
| Upstream (Parents) |
|---|
| (<<) GZMA → BTN3A3 |
| (<<) TRIM22 → BTN3A3 |
| (<<) GBP1 → BTN3A3 |
| (<<) HLA-DMB → BTN3A3 |
| (<<) UBE2L6 → BTN3A3 |
| Downstream (Children) |
|---|
| BTN3A3 → CXCL13 (>>) |
| BTN3A3 → LOC100133811///LOC100133661///LOC731718///ZNF749///RNASE2///HLA-DRB5///HLA-DRB4///HLA-DRB3///HLA-DRB2///HLA-DRB1 (>>) |
| BTN3A3 → MAB21L1 (>>) |
| BTN3A3 → UBASH3A (>>) |
| BTN3A3 → SP140 (>>) |
| BTN3A3 → CD69 (>>) |
| BTN3A3 → MX1 (>>) |
| BTN3A3 → FGD2 (>>) |
| BTN3A3 → APOBEC3G (>>) |
| BTN3A3 → GBP1 (>>) |
| BTN3A3 → BTN3A2 (>>) |
| BTN3A3 → PSMB9 (>>) |
| BTN3A3 → MYCL1 (>>) |
| BTN3A3 → ZMYM5 (>>) |
| BTN3A3 → UBE2L6 (>>) |
